A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples